Cited by 1,821Electroconvulsive Therapy StudiesPoisoning and overdose treatmentsPharmacovigilance and Adverse Drug Reactions

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

The Serotonin Syndrome

Boyer, Edward W., Shannon, Michael·2005·New England Journal of Medicine

DOI 10.1056/nejmra041867

Open this paper in CoChat — free account

Abstract

The serotonin syndrome is a potentially life-threatening drug reaction that may result from therapeutic medication use, self-poisoning, or interactions between drugs.

Integrity signals

Registry

Crossref · 10.1056/nejmra041867

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06783-3 · Cited by 3,025
The serotonin syndrome
Sternbach, H. A. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.6.705 · Cited by 1,349
The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity
Dunkley, E. J. C., Isbister, G. K., Sibbritt, D. W., Dawson, A. H., & Whyte, I. M. (2003) · QJM · doi:10.1093/qjmed/hcg109 · Cited by 1,032
Neuroleptic malignant syndrome
Levenson, J. L. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.10.1137 · Cited by 984
2002 annual report of the American association of poison control centers toxic exposure surveillance system
Watson, W. A., Litovitz, T. L., Rodgers, G. C., Klein‐Schwartz, W., Youniss, J., Rose, S. R., Borys, D. J., & May, M. E. (2003) · The American Journal of Emergency Medicine · doi:10.1016/s0735-6757(03)00088-3 · Cited by 481
Interactions Between Herbal Medicines and Prescribed Drugs
Izzo, A., & Ernst, E. (2012) · Drugs · doi:10.2165/00003495-200161150-00002 · Cited by 464
Relative Toxicity of Selective Serotonin Reuptake Inhibitors (SSRIs) in Overdose
Isbister, G. K., Bowe, S. J., Dawson, A. H., & Whyte, I. M. (2004) · Journal of Toxicology Clinical Toxicology · doi:10.1081/clt-120037428 · Cited by 432
The Libby Zion Case
Asch, D. A., & Parker, R. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198803243181209 · Cited by 396
Effects of Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy on Serotonergic Symptoms in Newborns and Cord Blood Monoamine and Prolactin Concentrations
Laine, K., Heikkinen, T., Ekblad, U., & Kero, P. O. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.720 · Cited by 329
Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity
Parrott, A. C. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00711-0 · Cited by 325

Show all 49 references

Research works printed but not linked: 8

Sampson E, 1999, Br J Gen Pract, 49, 867
Mackay FJ, 1999, Br J Gen Pract, 49, 871
Hoyer D, 1994, Pharmacol Rev, 46, 157
Saper CB. Brain stem modulation of sensation, movement, and consciousness. In: Kandel ER, Schwartz JH, Jessell TM, eds. Principles of neural science. 4th ed. New York: McGraw-Hill, 2000:896.
Kline SS, 1989, Clin Pharm, 8, 510
Whyte I, 2002, J Toxicol Clin Toxicol, 40, 668
Boddy R, 2004, J Toxicol Clin Toxicol, 42, 725
Olsen D, 2004, J Toxicol Clin Toxicol, 42, 744

Sorted by citations

Items 301–400 of 1,000

Myoclonus in the critically ill: Diagnosis, management, and clinical impact
Sutter, R., Ristic, A., Rüegg, S. J., & Fuhr, P. (2015) · Clinical Neurophysiology · doi:10.1016/j.clinph.2015.08.009 · Cited by 39
Inhibition of monoamine oxidase (MAO) by β-carbolines and their interactions in live neuronal (PC12) and liver (HuH-7 and MH1C1) cells
Santillo, M. F., Liu, Y., Ferguson, M. S., Vohra, S., & Wiesenfeld, P. L. (2014) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.12.006 · Cited by 38
The serotonin syndrome as a result of mephedrone toxicity
Garrett, G., & Sweeney, M. (2010) · BMJ Case Reports · doi:10.1136/bcr.04.2010.2925 · Cited by 39
Empirically supported use of psychiatric medications in adolescents and adults with IBD
Thorkelson, G., Bielefeldt, K., & Szigethy, E. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000734 · Cited by 39
Pharmacotherapy for Depression and Anxiety in the Primary Care Setting
Parish, A. L., Gillis, B. D., & Anthamatten, A. (2023) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2023.104556 · Cited by 42
Toxicology in the Critical Care Unit
Alapat, P., & Zimmerman, J. L. (2008) · CHEST Journal · doi:10.1378/chest.07-1840 · Cited by 38
Serotonin Syndrome in Elderly Patients Treated for Psychotic Depression with Atypical Antipsychotics and Antidepressants: Two Case Reports
Kohen, I., Gordon, M. L., & Manu, P. (2007) · CNS Spectrums · doi:10.1017/s1092852900021386 · Cited by 38
Utility of serum lactate to predict drug-overdose fatality
Manini, A. F., Kumar, A., Olsen, D., Vlahov, D., & Hoffman, R. S. (2010) · Clinical Toxicology · doi:10.3109/15563650.2010.504187 · Cited by 40
Etiologies and management of cutaneous flushing
Sadeghian, A., Rouhana, H., Stumpf, B., & Boh, E. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.12.031 · Cited by 38
Insights into Pathophysiology from Medication-induced Tremor
Morgan, J. C., Kurek, J. A., Davis, J. L., & Sethi, K. D. (2016) · PubMed Central · doi:10.7916/d83b75zp · Cited by 38
Molecular Dynamics Simulation of Tryptophan Hydroxylase-1: Binding Modes and Free Energy Analysis to Phenylalanine Derivative Inhibitors
Zhong, H., Huang, W., He, G., Peng, C. Y., Wu, F., & Ouyang, L. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14059947 · Cited by 38
The role of methylene blue in serotonin syndrome following cardiac transplantation: A case report and review of the literature
Grubb, K. J., Kennedy, J. L. W., Bergin, J. D., Groves, D. S., & Kern, J. A. (2012) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2012.07.030 · Cited by 37
Acute selective serotonin reuptake inhibitors regulate the dorsal raphe nucleus causing amplification of terminal serotonin release
Dankoski, E. C., Carroll, S., & Wightman, R. M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13528 · Cited by 39
Jimson weed (Datura stramonium L.) alkaloid extracts modulate cholinesterase and monoamine oxidase activities in vitro: possible modulatory effect on neuronal function
Ademiluyi, A. O., Ogunsuyi, O. B., Oboh, G., & Agbebi, O. J. (2016) · Comparative Clinical Pathology · doi:10.1007/s00580-016-2257-6 · Cited by 37
Serotonin syndrome: a clinical review of current controversies
Werneke, U., Truedson, P., Wikström, H., & Ott, M. (2020) · Journal of Integrative Neuroscience · doi:10.31083/j.jin.2020.04.314 · Cited by 37
Medication overuse and chronic migraine: a critical review according to clinical pharmacology
Ferrari, A., Baraldi, C., & Sternieri, E. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1043265 · Cited by 38
Management of serotonin syndrome (toxicity)
Chiew, A. L., & Isbister, G. K. (2024) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.16152 · Cited by 36
Drug-induced movement disorders
Zádori, D., Veres, G., Szalárdy, L., Klivènyi, P., & Vécsei, L. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1032244 · Cited by 36
New oxazolidinone derivatives as antibacterial agents with improved activity
Poce, G., Zappia, G., Porretta, G. C., Botta, B., & Biava, M. (2008) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.18.2.97 · Cited by 36
Perspectives on genetic animal models of serotonin toxicity
Kalueff, A. V., LaPorte, J. L., & Murphy, D. L. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.08.015 · Cited by 37
Better guidelines for better care: accounting for multimorbidity in clinical guidelines – structured examination of exemplar guidelines and health economic modelling
Guthrie, B., Thompson, A., Dumbreck, S., Flynn, A., Alderson, P., Nairn, M., Treweek, S. P., & Payne, K. (2017) · Health Services and Delivery Research · doi:10.3310/hsdr05160 · Cited by 36
Venlafaxine plus melatonin ameliorate reserpine-induced depression-like behavior in zebrafish
Tang, Y., Li, Z.-R., Zhang, S.-Z., Mi, P., Chen, D.-Y., & Feng, X. (2019) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2019.106835 · Cited by 34
Role of neurotransmitters in schizophrenia: a comprehensive study
Bansal, V., & Chatterjee, I. (2021) · Kuwait Journal of Science · doi:10.48129/kjs.v48i2.9264 · Cited by 38
Efficacy of Methylene Blue in an Experimental Model of Calcium Channel Blocker–Induced Shock
Jang, D. H., Donovan, S., Nelson, L. S., Bania, T. C., Hoffman, R. S., & Chu, J. (2014) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2014.09.015 · Cited by 36
Consistency of Drug–Drug and Gene–Drug Interaction Information in US FDA-Approved Drug Labels
Conrado, D. J., Rogers, H. L., Zineh, I., & Pacanowski, M. A. (2013) · Pharmacogenomics · doi:10.2217/pgs.12.203 · Cited by 36
High risk and low prevalence diseases: Thyroid storm
Farooqi, S., Raj, S., Koyfman, A., & Long, B. (2023) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2023.03.035 · Cited by 45
Prevalence and clinical features associated to bipolar disorder–migraine comorbidity: a systematic review
Fornaro, M., Berardis, D. D., Pasquale, C. D., Indelicato, L., Pollice, R., Valchera, A., Perna, G., Iasevoli, F., Tomasetti, C., Martinotti, G., et al. (2014) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2014.09.020 · Cited by 35
Role of 5-HT1A- and 5-HT2A receptors for the murine model of the serotonin syndrome
Haberzettl, R., Fink, H., & Bert, B. (2014) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2014.07.003 · Cited by 35
Incidence of Serotonin Syndrome With Combined Use of Linezolid and Serotonin Reuptake Inhibitors Compared With Linezolid Monotherapy
Karkow, D., Kauer, J., & Ernst, E. J. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000751 · Cited by 36
Concentration-Dependent Activity of Hydromethylthionine on Clinical Decline and Brain Atrophy in a Randomized Controlled Trial in Behavioral Variant Frontotemporal Dementia
Shiells, H., Schelter, B. O., Bentham, P., Baddeley, T. C., Rubino, C. M., Ganesan, H., Hammel, J., Vuksanović, V., Staff, R. T., Murray, A. D., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191173 · Cited by 34
Life-threatening serotonin toxicity due to a citalopram-fluconazole drug interaction: case reports and discussion.
Levin, T., Cortes-Ladino, A., Weiss, M., & Palomba, M. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2008.03.008 · Cited by 35
Management of Serotonin Syndrome and Neuroleptic Malignant Syndrome
Katus, L. E., & Frucht, S. J. (2016) · Current Treatment Options in Neurology · doi:10.1007/s11940-016-0423-4 · Cited by 35
Potential drug–drug interactions within Veterans Affairs medical centers
Mahmood, M. H., Malone, D. C., Skrepnek, G. H., Abarca, J., Armstrong, E. P., Murphy, J. E., Grizzle, A. J., Ko, Y., & Woosley, R. L. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060548 · Cited by 35
Examining the paradoxical effects of kratom: a narrative inquiry
Smith, K. E., Feldman, J. D., Dunn, K. E., McCurdy, C. R., Weiss, S. T., Grundmann, O., Garcia‐Romeu, A., Nichels, J., & Epstein, D. H. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1174139 · Cited by 34
The general approach to the poisoned patient
Thompson, T. M., Theobald, J. L., Lu, J. J., & Erickson, T. B. (2014) · Disease-a-Month · doi:10.1016/j.disamonth.2014.10.002 · Cited by 34
Synthesis, structure–activity relationships and molecular modeling studies of new indole inhibitors of monoamine oxidases A and B
Regina, G. L., Silvestri, R., Gatti, V., Lavecchia, A., Novellino, E., Befani, O., Turini, P., & Agostinelli, E. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.09.072 · Cited by 34
Fish Capsules: A System for High‐Throughput Screening of Combinatorial Drugs
Tang, M., Duan, X., Yang, A., He, S., Zhou, Y., Liu, Y., Zhang, L., Luo, X., Shi, P., Li, H., et al. (2022) · Advanced Science · doi:10.1002/advs.202104449 · Cited by 34
5-HT1A/1B Receptors as Targets for Optimizing Pigmentary Responses in C57BL/6 Mouse Skin to Stress
Wu, H., Pang, S., Liu, Q., Wang, Q., Cai, M., & Shang, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089663 · Cited by 35
Dexmedetomidine to Treat Lisdexamfetamine Overdose and Serotonin Toxidrome in a 6-Year-Old Girl
Akingbola, O., & Singh, D. (2012) · American Journal of Critical Care · doi:10.4037/ajcc2012768 · Cited by 34
Evaluation and Management of Children With Acute Mental Health or Behavioral Problems. Part II: Recognition of Clinically Challenging Mental Health Related Conditions Presenting With Medical or Uncertain Symptoms
Chun, T. H., Mace, S. E., Katz, E. R., Shook, J. E., Chun, T. H., Conners, G. P., Conway, E. E., Dudley, N. C., Fuchs, S. M., Lane, N., et al. (2016) · PEDIATRICS · doi:10.1542/peds.2016-1573 · Cited by 36
Revival of an antidote: bedside experience with physostigmine
Rasimas, J. J., Sachdeva, K. K., & Donovan, J. W. (2018) · Toxicology Communications · doi:10.1080/24734306.2018.1535538 · Cited by 34
Psychopharmacology in Pediatric Critical Care
Stoddard, F. J., Usher, C. T., & Abrams, A. N. (2006) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2006.02.005 · Cited by 34
Tramadol toxicity in a cat: case report and literature review of serotonin syndrome
Indrawirawan, Y., & McAlees, T. (2014) · Journal of Feline Medicine and Surgery · doi:10.1177/1098612x14539088 · Cited by 33
Burden and Management of Multidrug-Resistant Organisms in Palliative Care
Datta, R., & Juthani‐Mehta, M. (2017) · Palliative Care Research and Treatment · doi:10.1177/1178224217749233 · Cited by 33
Recent advances in antiemetics: new formulations of 5HT3-receptor antagonists
Gilmore, J., D’Amato, S., Griffith, N. L., & Schwartzberg, L. S. (2018) · Cancer Management and Research · doi:10.2147/cmar.s166912 · Cited by 33
Common Substances of Abuse
Wang, G. S., & Hoyte, C. O. (2018) · Pediatrics in Review · doi:10.1542/pir.2017-0267 · Cited by 33
Association of Linezolid With Risk of Serotonin Syndrome in Patients Receiving Antidepressants
Bai, A. D., McKenna, S., Wise, H., Loeb, M. B., & Gill, S. S. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.47426 · Cited by 36
Movement disorders emergencies
Munhoz, R. P., Scorr, L., & Factor, S. A. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000212 · Cited by 33
Serotonin Syndrome Induced by Tramadol Intoxication in an 8-Month-Old Infant
Maréchal, C., Honorat, R., & Claudet, I. (2010) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2010.08.005 · Cited by 33
Full recovery after severe serotonin syndrome, severe rhabdomyolysis, multi-organ failure and disseminated intravascular coagulopathy from MDMA
Davies, O., Batajoo-Shrestha, B., Sosa-Popoteur, J., & Olibrice, M. (2014) · Heart & Lung · doi:10.1016/j.hrtlng.2013.11.009 · Cited by 33
Pharmacotherapy of Fibromyalgia
Mease, P. J., & Choy, E. (2009) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2009.06.007 · Cited by 31
The Serotonin Syndrome
Gnanadesigan, N., Espinoza, R. T., & Smith, R. L. (2005) · New England Journal of Medicine · doi:10.1056/nejm200506093522320 · Cited by 33
Venlafaxine-Associated Serotonin Syndrome Causing Severe Rhabdomyolysis and Acute Renal Failure in a Patient With Idiopathic Parkinson Disease
Rajapakse, S., Abeynaike, L., & Wickramarathne, T. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181ee2ae7 · Cited by 32
Antiinflammatory and neurological activity of pyrithione and related sulfur-containing pyridine N-oxides from Persian shallot (Allium stipitatum)
Krejčová, P., Kučerová, P., Stafford, G. I., Jäger, A. K., & Kubec, R. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.03.066 · Cited by 32
Toxicology in the ICU
Brooks, D. E., Levine, M., O’Connor, A. D., French, R. N. E., & Curry, S. C. (2011) · CHEST Journal · doi:10.1378/chest.10-2726 · Cited by 32
Serotonin syndrome triggered by a single dose of suboxone
Isenberg, D. L., Wong, S. C., & Curtis, J. A. (2008) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2008.01.039 · Cited by 32
Evaluating postoperative fever
Maday, K. R., Hurt, J. B., Harrelson, P., & Porterfield, J. R. (2016) · JAAPA · doi:10.1097/01.jaa.0000496951.72463.de · Cited by 32
Biomolecular aspects of depression: A retrospective analysis
Peacock, B. N., Scheiderer, D. J., & Kellermann, G. H. (2016) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2016.11.002 · Cited by 36
Serotonin Syndrome Associated With Clozapine Withdrawal
Stevenson, E., Schembri, F., Green, D. M., & Burns, J. D. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.95 · Cited by 39
Postural induced‐tremor in psychiatry
Arbaizar, B., Gómez‐Acebo, I., & Llorca, J. (2008) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2008.01877.x · Cited by 31
Serotonin Toxicity
Moss, M. J., & Hendrickson, R. G. (2019) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001121 · Cited by 31
Nonclinical Evaluation of Antibacterial Oxazolidinones Contezolid and Contezolid Acefosamil with Low Serotonergic Neurotoxicity
Wang, W., Voss, K., Liu, J., & Gordeev, M. F. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00524 · Cited by 33
Prevalence of potentially harmful multidrug interactions on medication lists of elderly ambulatory patients
Anand, T. V., Wallace, B. K., & Chase, H. S. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02594-z · Cited by 35
Mild serotonin syndrome: A report of 12 cases
Prakash, S., Patel, V. J., Kakked, S., Patel, I., & Yadav, R. (2015) · Annals of Indian Academy of Neurology · doi:10.4103/0972-2327.150612 · Cited by 31
The Blue Coma: The Role of Methylene Blue in Unexplained Coma After Cardiac Surgery
Martino, E. A., Winterton, D., Nardelli, P., Pasin, L., Calabró, M. G., Bove, T., Fanelli, G. F., Zangrillo, A., & Landoni, G. (2015) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2015.09.011 · Cited by 33
Drug‐induced Movement Disorders in Children
Gilbert, D. L. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1444.005 · Cited by 32
A case of serotonin syndrome precipitated by abuse of the anticough remedy dextromethorphan in a bipolar patient treated with fluoxetine and lithium
Navarro, A., Perry, C., & Bobo, W. V. (2005) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2005.06.008 · Cited by 31
Cerebrovascular and cardiovascular diseases caused by drugs of abuse
Akasaki, Y., & Ohishi, M. (2020) · Hypertension Research · doi:10.1038/s41440-019-0367-7 · Cited by 30
Antidepressant use in ambulatory cancer patients
Kim, H. F., & Fisch, M. J. (2006) · Current Oncology Reports · doi:10.1007/s11912-006-0033-5 · Cited by 30
SSRIs as Moral Enhancement Interventions: A Practical Dead End
Wiseman, H. (2014) · AJOB Neuroscience · doi:10.1080/21507740.2014.911214 · Cited by 30
Drug-induced Hyperthermic Syndromes in Psychiatry
Caroff, S. N., Watson, C. B., & Rosenberg, H. R. (2021) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2021.19.1.1 · Cited by 30
Serotonergic Antidepressants and Linezolid: A Retrospective Chart Review and Presentation of Cases
Lorenz, R. A., VandenBerg, A., & Canepa, E. A. (2008) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.38.1.h · Cited by 30
Serotonin syndrome following cardiac surgery
SHANMUGAM, G., Kent, B., Alsaiwadi, T., & Baskett, R. J. F. (2008) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1510/icvts.2007.173104 · Cited by 30
Anticipating Potential Linezolid-SSRI Interactions in the General Hospital Setting: An MAOI in Disguise
Sola, C. L., Bostwick, J. M., Hart, D. A., & Lineberry, T. W. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.3.330 · Cited by 30
Dopaminergic neurones: much more than dopamine?
Seutin, V. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706328 · Cited by 30
Extracting value from case reports: lessons from serotonin toxicity
Gillman, P. K. (2006) · Anaesthesia · doi:10.1111/j.1365-2044.2006.04588.x · Cited by 30
Sudden adult death
Langlois, N. E. I. (2009) · Forensic Science Medicine and Pathology · doi:10.1007/s12024-009-9099-3 · Cited by 31
Neurological entanglements: The case of paediatric depressions, SSRIs and suicidal ideation
Wilson, E. (2011) · Subjectivity · doi:10.1057/sub.2011.12 · Cited by 29
Emerging toxicity of 5,6-methylenedioxy-2-aminoindane (MDAI): Pharmacokinetics, behaviour, thermoregulation and LD50 in rats
Páleníček, T., Lhotková, E., Žídková, M., Balı́ková, M., Kuchař, M., Himl, M., Cihlářová, P., Čegan, M., Valeš, K., Tylš, F., et al. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.04.004 · Cited by 29
Enhanced serotonin signaling stimulates ordered intestinal mucosal growth
Tackett, J. J., Gandotra, N., Bamdad, M. C., Muise, E. D., & Cowles, R. A. (2016) · Journal of Surgical Research · doi:10.1016/j.jss.2016.09.036 · Cited by 29
Medullary serotonergic system
Benarroch, E. E. (2014) · Neurology · doi:10.1212/wnl.0000000000000806 · Cited by 29
Psychopharmacologic treatment of pediatric major depressive disorder
Boylan, K., Romero, S., & Birmaher, B. B. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0442-z · Cited by 29
Methylene Blue-Associated Serotonin Syndrome: A ‘Green’ Encephalopathy After Parathyroidectomy
Rowley, M., Riutort, K. T., Shapiro, D., Casler, J. D., Festić, E., & Freeman, W. D. (2009) · Neurocritical Care · doi:10.1007/s12028-009-9206-z · Cited by 29
Uncovering the potential risk of serotonin toxicity in Australian veterans using pharmaceutical claims data
Ringland, C. L., Mant, A., McGettigan, P., Mitchell, P. B., Kelman, C., Buckley, N. A., & Pearson, S. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03253.x · Cited by 29
Aberrant accumulation of serotonin in dopaminergic neurons
Mößner, R., Simantov, R., Marx, A., Lesch, K., & Seif, I. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.02.081 · Cited by 29
Serotonin Syndrome Precipitated by Linezolid in a Medically Ill Patient on Duloxetine
Strouse, T. B., Kerrihard, T. N., Forscher, C. A., & Zakowski, P. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000239793.29449.75 · Cited by 29
Serotonin Syndrome in the Perioperative Period
Altman, C. S., & Jahangiri, M. F. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181c76be9 · Cited by 29
Serotonin syndrome following a single 50 mg dose of sertraline in a child
Phan, H., Casavant, M. J., Crockett, S. C., Lee, A. J., Hall, M. W., & Nahata, M. C. (2008) · Clinical Toxicology · doi:10.1080/15563650801938654 · Cited by 29
Exploring Hallucinogen Pharmacology and Psychedelic Medicine with Zebrafish Models
Kyzar, E. J., & Kalueff, A. V. (2016) · Zebrafish · doi:10.1089/zeb.2016.1251 · Cited by 31
Medical Attributes of St. John’s Wort (Hypericum perforatum)
(2004) · CRC Press eBooks · doi:10.1201/9780203025901-43 · Cited by 29
Serotonin syndrome induced by augmentation of SSRI with methylphenidate
Ishii, M., Tatsuzawa, Y., Yoshino, A., & Nomura, S. (2008) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2008.01767.x · Cited by 29
Review of the choice and use of antidepressant drugs
Bleakley, S. (2013) · Progress in Neurology and Psychiatry · doi:10.1002/pnp.311 · Cited by 28
‘Designer drugs’: update on the management of novel psychoactive substance misuse in the acute care setting
Smith, C. D., & Robert, S. (2014) · Clinical Medicine · doi:10.7861/clinmedicine.14-4-409 · Cited by 28
The Diagnosis of Psychosis
Cardinal, R. N., & Bullmore, E. T. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511686917 · Cited by 28
Bupropion Induced Serotonin Syndrome: A Case Report
Thorpe, E. L., Pizon, A. F., Lynch, M. J., & Boyer, J. J. (2010) · Journal of Medical Toxicology · doi:10.1007/s13181-010-0021-x · Cited by 28
Serotonin syndrome: fentanyl and selective serotonin reuptake inhibitor interactions.
Greenier, E., Лукьянова, В. Н., & Reede, L. J. (2014) · PubMed · Cited by 27
Increased postpartum haemorrhage, the possible relation with serotonergic and other psychopharmacological drugs: a matched cohort study
Heller, H. M., Ravelli, A. C. J., Bruning, A. H. L., de Groot, C. J. M., Scheele, F., van Pampus, M. G., & Honig, A. (2017) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-017-1334-4 · Cited by 27
CYP2D6 increases toxicity of the designer drug 4-methylthioamphetamine (4-MTA)
Carmo, H., Brulport, M., Hermes, M., Oesch, F., de Boer, D., Remião, F., Carvalho, F. D., Schön, M. R., Krebsfaenger, N., Doehmer, J., et al. (2006) · Toxicology · doi:10.1016/j.tox.2006.10.024 · Cited by 27
Cannabinoids and monoamine neurotransmission with focus on monoamine oxidase
Fišar, Z. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.12.010 · Cited by 28
A novel MDMA analogue, UWA‐101, that lacks psychoactivity and cytotoxicity, enhances l ‐DOPA benefit in parkinsonian primates
Johnston, T. H., Millar, Z. A., Huot, P., Wagg, K., Thiele, S. L., Salomonczyk, D., Yong-Kee, C. J., Gandy, M. N., McIldowie, M. J., Lewis, K. D., et al. (2012) · The FASEB Journal · doi:10.1096/fj.11-195016 · Cited by 27

Authors: Boyer, E. W., & Shannon, M.
Affiliations: Boston Children's Hospital (US)
ORCID: Boyer, Edward W.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2005-03-17
Volume: 352
Issue: 11
Pages: 1112-1120
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra041867
OpenAlex: W2123778879
Cited by: 1,821
References: 49
Citations by year: 2026: 47 · 2025: 65 · 2024: 84 · 2023: 53 · 2022: 78 · 2021: 74 · 2020: 92 · 2019: 86 · 2018: 99 · 2017: 96 · 2016: 98 · 2015: 112 · 2014: 121 · 2013: 109 · 2012: 93
FWCI: 11.96
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Drug Abuse (DA14929, R21DA014929)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Keywords: serotonin syndrome, adverse drug reactions, drug interactions, self-poisoning, serotonin receptor agonists
MeSH terms: Algorithms, Antidepressive Agents, Diagnostic Errors, Drug Interactions, Humans, Monoamine Oxidase Inhibitors, Selective Serotonin Reuptake Inhibitors, Serotonin Syndrome, Drug Overdose

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Serotonin Syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks